Immuron (IMRN) Change in Account Payables (2016 - 2023)
Immuron (IMRN) recorded quarterly Change in Account Payables of -$6.3 million in Q4 2023, down 1501.45% quarter-over-quarter from $451865.3 in Q2 2021.
Immuron (IMRN) Change in Account Payables (2016 - 2023) Analysis & Trends
Immuron's Change in Account Payables history runs 5 years deep, the most recent figure standing at -$6.3 million for Q4 2023.
- In Q4 2023, Change in Account Payables changed N/A year-over-year to -$6.3 million; the TTM figure through Dec 2023 stood at -$9.5 million (changed N/A YoY), while the FY2025 annual figure was -$393036.6, down 167.33% from the prior year.
- Change in Account Payables was -$6.3 million for Q4 2023 at Immuron, down from $451865.3 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $451865.3 in Q2 2021 to a low of -$6.3 million in Q4 2023.
- Historically, Change in Account Payables has averaged -$2.0 million across 3 years, with a median of -$237548.7 in 2020.
- Biggest YoY gain for Change in Account Payables was 290.22% in 2021; the steepest drop was 290.22% in 2021.
- A 3-year view of Change in Account Payables shows it stood at -$237548.7 in 2020, then jumped by 290.22% to $451865.3 in 2021, then tumbled by 1501.45% to -$6.3 million in 2023.
- The last three Change in Account Payables figures came in at -$6.3 million (Q4 2023), $451865.3 (Q2 2021), and -$237548.7 (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -6.33 Mn |
| Dec 31, 2023 | -6.33 Mn |
| Jun 30, 2021 | 451,865.28 |
| Jun 30, 2021 | 451,865.28 |
| Jun 30, 2020 | -237,548.69 |
| Jun 30, 2020 | -237,548.69 |
| Dec 31, 2017 | -3.40 Mn |
| Dec 31, 2017 | -3.40 Mn |
| Dec 31, 2016 | 3.34 Mn |
| Dec 31, 2016 | 3.34 Mn |